Daejeon, South Korea

Kyung Seob Lim

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyung Seob Lim. Retrieved from https://idiyas.com/inventor/kyung-seob-lim-n4b0tmit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyung Seob Lim: Innovator in Genetic Research

Introduction

Kyung Seob Lim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of genetic research, particularly in the development of animal models for studying genetic mutations.

Latest Patents

Kyung Seob Lim holds a patent for a groundbreaking invention titled "Dwarfism Animal Model Having IGF-1 Genetic Mutation and Method for Producing Same." This patent represents a significant advancement in understanding dwarfism and its genetic underpinnings.

Career Highlights

Lim is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work focuses on genetic mutations and their implications for biological research and medical applications.

Collaborations

He collaborates with notable colleagues, including Kyu Tae Chang and Bo Woong Sim, to further enhance the impact of his research in the scientific community.

Conclusion

Kyung Seob Lim's innovative work in genetic research exemplifies the importance of scientific inquiry in understanding complex genetic conditions. His contributions continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…